Ann: Reinstatement to Official Quotation, page-63

Hilarious how much people are foaming at the mouth for SKN's "20,000 tubes per month" output, when ANO is in the vicinity of 3000 tonnes output for just one of their current products.

Let alone what else they can do with other product lines and commercialised IP.

Unlike the pretenders, ANO is already a diversified global business, cashed up, debt free, extremely profitable, existing relationships with some of the largest businesses in the industry, and actually owns multiple TGA-registered facilities, plus an end-product clean room and testing laboratory, to produce listed medicines in-house without needing to use contracted third-parties.